References
- Qian BZ, Pollard J. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39–51.
- Mosser D, Edwards J. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958–969.
- Lewis CE, Pollard J. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66: 605–612.
- Tsukada N, Burger JA, Zvaifler NJ, Kipps TJ. Distinctive features of ‘nurselike’ cells that differentiate in the context of chronic lymphocytic leukemia. Blood 2002;99:1030–1037.
- Burger M, Hartmann T, Krome M, et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 2005;106:1824–1830.
- Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006;177:7303–7311.
- ChangYC, ChenTC, LeeCT, et al. Epigenetic control of MHC class II expression in tumor-associated macro- phages by decoy receptor 3. Blood2008;111:5054–5063.
- ClearAJ, LeeAM, CalaminiciM, et al. Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment. Blood2010;115:5053–5056.